These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 16775665

  • 21. [Effects of anti-platelet drugs on myocardial no-reflow after acute myocardial infarction and reperfusion: experiment with mini-swine model].
    Zhao JL, Yang YJ, Wu YJ, Jing ZC, You SJ, Yang WX, Meng L, Tian Y, Chen JL, Gao RL, Chen ZJ.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 17; 85(31):2187-91. PubMed ID: 16321182
    [Abstract] [Full Text] [Related]

  • 22. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
    Yetgin T, Uitterdijk A, Te Lintel Hekkert M, Merkus D, Krabbendam-Peters I, van Beusekom HMM, Falotico R, Serruys PW, Manintveld OC, van Geuns RM, Zijlstra F, Duncker DJ.
    JACC Cardiovasc Interv; 2015 Dec 28; 8(15):1990-1999. PubMed ID: 26738671
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Intravenous nicorandil preserves endothelial junctions by decreasing endothelin-1 via activation of ATP-sensitive K+ channel.
    Zhao JL, Yang YJ, Zhang YH, Pei WD, Sun YH, Zhai M, Gao RL.
    Vasa; 2007 Aug 28; 36(3):175-9. PubMed ID: 18019273
    [Abstract] [Full Text] [Related]

  • 25. Pretreatment with fosinopril or valsartan reduces myocardial no-reflow after acute myocardial infarction and reperfusion.
    Zhao JL, Yang YJ, You SJ, Jing ZC, Wu YJ, Cheng JL, Gao RL.
    Coron Artery Dis; 2006 Aug 28; 17(5):463-9. PubMed ID: 16845255
    [Abstract] [Full Text] [Related]

  • 26. Pretreatment with Tongxinluo protects porcine myocardium from ischaemia/reperfusion injury through a nitric oxide related mechanism.
    Cheng YT, Yang YJ, Zhang HT, Qian HY, Zhao JL, Meng XM, Luo FL, Wu YL.
    Chin Med J (Engl); 2009 Jul 05; 122(13):1529-38. PubMed ID: 19719943
    [Abstract] [Full Text] [Related]

  • 27. [Ischemic preconditioning attenuates myocardial no-reflow and reperfusion injury after revascularization of acute myocardial infarction by reducing myocardial edema via the protein kinase A pathway].
    Li XD, Yang YJ, Zhao JL, Zhang HT, Cheng YT, Tian Y, Meng XM, Cui HH, Wang TJ.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Nov 05; 40(11):945-51. PubMed ID: 23363677
    [Abstract] [Full Text] [Related]

  • 28. No reflow phenomenon in coronary heart disease.
    Ito H.
    J Cardiol; 2001 Nov 05; 37 Suppl 1():39-42. PubMed ID: 11433826
    [Abstract] [Full Text] [Related]

  • 29. Intracoronary verapamil for reversal of no-reflow during coronary angioplasty for acute myocardial infarction.
    Werner GS, Lang K, Kuehnert H, Figulla HR.
    Catheter Cardiovasc Interv; 2002 Dec 05; 57(4):444-51. PubMed ID: 12455077
    [Abstract] [Full Text] [Related]

  • 30. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
    Rousseau G, Provost P, Tran D, Caillé G, Latour JG.
    J Pharmacol Exp Ther; 1994 Mar 05; 268(3):1252-60. PubMed ID: 8138938
    [Abstract] [Full Text] [Related]

  • 31. The preventive effect of garlicin on a porcine model of myocardial infarction reperfusion no-reflow.
    Li JH, Yang P, Li AL, Wang Y, Shi ZX, Ke YN, Li XL.
    Chin J Integr Med; 2014 Jun 05; 20(6):425-9. PubMed ID: 22539198
    [Abstract] [Full Text] [Related]

  • 32. Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow.
    Li JH, Yang P, Li AL, Wang Y, Ke YN, Li XL.
    J Zhejiang Univ Sci B; 2011 Aug 05; 12(8):638-43. PubMed ID: 21796804
    [Abstract] [Full Text] [Related]

  • 33. Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.
    Zhao XJ, Liu XL, He GX, Xu HP.
    Braz J Med Biol Res; 2014 Feb 05; 47(3):245-51. PubMed ID: 24554037
    [Abstract] [Full Text] [Related]

  • 34. REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER).
    Huang D, Qian J, Ge L, Jin X, Jin H, Ma J, Liu Z, Zhang F, Dong L, Wang X, Yao K, Ge J.
    Am Heart J; 2012 Sep 05; 164(3):394-401. PubMed ID: 22980307
    [Abstract] [Full Text] [Related]

  • 35. Garlicin attenuates reperfusion no-reflow in a catheter-based porcine model of acute myocardial infarction.
    Peng Y, Jiahui L, Aili L, Yong W, Zaixiang S, Yuannan K, Xianlun L.
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Aug 05; 40(4):285-9. PubMed ID: 22471597
    [Abstract] [Full Text] [Related]

  • 36. Effects of calcium-channel blockers on myocardial preservation during experimental acute myocardial infarction.
    Reimer KA, Jennings RB.
    Am J Cardiol; 1985 Jan 25; 55(3):107B-115B. PubMed ID: 3881903
    [Abstract] [Full Text] [Related]

  • 37. Infarct size reduction with coronary venous retroinfusion of diltiazem in the acute occlusion/reperfusion porcine heart model.
    Tadokoro H, Miyazaki A, Satomura K, Rydén L, Kaul S, Kar S, Corday E, Drury K.
    J Cardiovasc Pharmacol; 1996 Jul 25; 28(1):134-41. PubMed ID: 8797147
    [Abstract] [Full Text] [Related]

  • 38. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
    Kerendi F, Kin H, Halkos ME, Jiang R, Zatta AJ, Zhao ZQ, Guyton RA, Vinten-Johansen J.
    Basic Res Cardiol; 2005 Sep 25; 100(5):404-12. PubMed ID: 15965583
    [Abstract] [Full Text] [Related]

  • 39. Beneficial effects of diltiazem during myocardial reperfusion: a randomized trial in acute myocardial infarction.
    Pizzetti G, Mailhac A, Li Volsi L, Di Marco F, Lu C, Margonato A, Chierchia SL.
    Ital Heart J; 2001 Oct 25; 2(10):757-65. PubMed ID: 11721720
    [Abstract] [Full Text] [Related]

  • 40. Short-term low dose intracoronary diltiazem administered at the onset of reperfusion reduces myocardial infarct size.
    Herzog WR, Vogel RA, Schlossberg ML, Edenbaum LR, Scott HJ, Serebruany VL.
    Int J Cardiol; 1997 Mar 25; 59(1):21-7. PubMed ID: 9080022
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.